X Financial (XYF) Q1 2026 Earnings Transcript

X Financial reported Q1 2026 net revenue of RMB 1.18 billion, down 39.3% year over year, while net income fell to RMB 37.9 million from RMB 458.1 million a year ago as provisions remained elevated at RMB 282.9 million. Loan origination dropped 58.4% to RMB 14.63 billion and active borrowers declined 60.6%, reflecting a deliberate pullback amid tighter underwriting and regulatory uncertainty. Management guided Q2 2026 loan origination to RMB 11.5 billion-RMB 12.5 billion and warned that new regulatory requirements could materially and adversely affect results, though liquidity and capital remain solid with RMB 2.4 billion in cash and ongoing buybacks.

Analysis

XYF is shifting from a growth comp to a capital-preservation story, and that usually compresses valuation twice: first on lower top-line optionality, then on reduced credit-cycle earnings power. The key second-order effect is that management’s decision to pull back now likely improves survivability but also hands share to larger or less regulated competitors that can keep underwriting while XYF sits on the sidelines. In a stressed consumer-credit tape, the market should care less about the absolute margin rebound and more about the fact that earnings are now structurally hostage to regulation and delinquency migration.

The credit curve matters more than the headline NPL proxy. The move up in longer-dated delinquencies while near-term delinquencies improve is a classic sign of “risk pushed forward,” meaning provisions can look better for a quarter or two before rolling back higher as the seasoning bucket catches up. That creates a setup where any apparent stabilization in Q2 could be a trap: lower originations reduce near-term charge-offs but also shrink the future fee base, so EPS may look supported only because management is starving the book.

The buyback is supportive but likely not enough to offset rerating risk unless the company can prove regulatory clarity and sustained provision normalization. With a strong cash position and modest leverage, the equity has downside protection versus more levered lenders, but that same balance sheet also implies management may continue to prioritize de-risking over maximizing ROE. Consensus may be underestimating how hard it is to re-accelerate origination once underwriting is tightened and borrower acquisition channels are reset; the business can stabilize, but a return to prior profit levels looks years, not quarters, away.

Key Decisions for Investors

• Short XYF on strength into the next 1-3 weeks; use any post-earnings bounce to establish a tactical position with a 10-15% downside target and a tight cover if management signals easing of provisioning or regulatory clarity.
• If you need event-driven optionality, buy XYF put spreads 1-2 months out to express continued deleveraging of the earnings base; structure for a move lower on any Q2 guidance miss or further delinquency deterioration.
• Pair trade: long a higher-quality, less regulation-sensitive consumer credit / fintech name and short XYF to isolate the regulatory and underwriting-dislocation discount; the trade works if credit stress remains industry-wide but risk appetite rotates toward scalable platforms.
• Avoid fading the buyback headline with outright longs unless you are underwriting a prolonged capital return story; buybacks here are a floor, not a catalyst, and the path to multiple expansion likely requires 2-3 quarters of stable delinquency data.
• For portfolio hedging, treat XYF as a small-cap China consumer-credit beta short against a basket of domestically oriented financials if policy headlines worsen; the stock should underperform first on regulatory ambiguity and only later on reported earnings.